This inventor holds 2 USPTO granted patents. Top assignee: Colorcon Incorporated. Active years: 1985-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1987
Title: **The Innovative Contributions of Louis F D'Andrea**
Introduction
Louis F D'Andrea, an accomplished inventor based in King of Prussia, PA, has made significant contributions to the pharmaceutical industry. Known for his innovative approach, he holds two patents that focus on enteric film-coating compositions, which are crucial for the effective delivery of pharmaceutical tablets.
Latest Patents
D'Andrea's latest patents involve a non-toxic edible enteric film coating, consisting of both a dry powder and an aqueous suspension specifically designed for coating pharmaceutical tablets. His inventions include not only the enteric coated tablets but also detailed methods for creating both the dry powder and aqueous coating suspension. These advancements facilitate the effective coating of tablets, ensuring that they can safely and effectively deliver their active ingredients to the intended site in the gastrointestinal tract.
Career Highlights
Louis F D'Andrea currently works with Colorcon Incorporated, a company renowned for its expertise in pharmaceutical coatings and delivery systems. His work at Colorcon underscores his commitment to advancing the efficacy of drug formulations, helping to enhance patient safety and compliance through innovative solutions.
Collaborations
Throughout his career, D'Andrea has collaborated with notable colleagues, including Stuart C Porter and Edward J Woznicki. These partnerships have fostered an environment of creativity and shared expertise, leading to the successful development of cutting-edge technologies in the field of pharmaceutical coatings.
Conclusion
In summary, Louis F D'Andrea exemplifies the spirit of innovation through his work in developing enteric film-coating compositions. His patents not only enhance the pharmaceutical industry's capabilities but also demonstrate the ongoing need for innovation in drug delivery systems, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile